Igor Belyakov

Title: Igor Belyakov: Innovator in Immunology

Introduction

Igor Belyakov is a prominent inventor based in Gaithersburg, MD (US). He has made significant contributions to the field of immunology, particularly through his innovative patents. With a total of 2 patents, Belyakov's work focuses on enhancing immune responses and developing methods for treating infections.

Latest Patents

Belyakov's latest patents include "Immunostimulatory combinations of TLR ligands and methods of use." This invention provides immunostimulatory combinations of TLR ligands and therapeutic methods that involve administering these combinations to a subject. The described combinations can elicit an increased immune response compared to other existing immunostimulatory combinations. Another notable patent is "Mucosal cytotoxic T lymphocyte responses," which outlines methods for inducing an antigen-specific, mucosal cytotoxic T lymphocyte response. This response is useful in preventing and treating infections caused by pathogens that enter through mucosal surfaces.

Career Highlights

Igor Belyakov is affiliated with the National Institutes of Health, a component of the US Department of Health & Human Services. His work at this esteemed institution has allowed him to focus on groundbreaking research in immunology and contribute to advancements in therapeutic methods.

Collaborations

Belyakov has collaborated with notable colleagues, including Jay A Berzofsky and Michael A Derby. These collaborations have further enriched his research and innovation in the field.

Conclusion

Igor Belyakov's contributions to immunology through his patents and research at the National Institutes of Health highlight his role as a key innovator in the field. His work continues to pave the way for advancements in immune response therapies.